Physiogenex at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Physiogenex brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program centres on metabolic studies of semaglutide and related weight-loss drugs in obese hamsters. One study compares the benefits of semaglutide, tirzepatide and retatrutide, and another uses individual metabolic phenotyping to capture the acute effects of semaglutide.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Preclinical contract research company specializing in metabolic and cardiometabolic disease models. | Poster Sat Nov 14 7:30pm–8:30pm Semaglutide, Tirzepatide and Retatrutide Promote Metabolic Benefits in Obese Hamsters Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Individual Metabolic Phenotyping Uncovers the Acute Effects of Semaglutide in Hamsters Metabolism and integrative physiology |
Find decision makers at Physiogenex
Tell us what you sell and we’ll find the people at Physiogenex most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction